Barclays’s Clene CLNN Stock Holding History

Barclays’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$140	–	5124
2022 Q4	$140	Sell	7 -26	-79%	-$603	﹤0.01%	5195
2022 Q3	$2K	Sell	33 -8	-20%	-$530	﹤0.01%	4624
2022 Q2	$2K	Sell	41 -125	-75%	-$6.98K	﹤0.01%	4875
2022 Q1	$13K	Buy	+166	New	+$10K	﹤0.01%	4545

Other funds holding CLNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Barclays's CLNN Position: Q1 2023 in Review

Barclays sold out of Clene (CLNN) in Q1 2023, closing a stake of 7 shares — an estimated $140 sold.

Barclays first reported a position in CLNN in Q1 2022 and held it in 4 quarters. The position peaked at $13K in Q1 2022. 31 funds tracked by Wall St. Rank hold CLNN as of Q1 2023.

Barclays reported no remaining Clene position as of Q1 2023 after selling out during the quarter.
Barclays sold 7 Clene shares in Q1 2023, an estimated $140.
Barclays first reported a position in Clene in Q1 2022 and held it in 4 quarters.
Barclays's Clene position peaked at $13K in Q1 2022.
31 funds tracked by Wall St. Rank held Clene as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.